• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ONC201激活的酪蛋白水解蛋白酶P(CLPP)通过诱导线粒体功能障碍抑制人上皮性卵巢癌细胞的增殖并促进其凋亡。

Caseinolytic protease P (CLPP) activated by ONC201 inhibits proliferation and promotes apoptosis in human epithelial ovarian cancer cells by inducing mitochondrial dysfunction.

作者信息

Kou Xinxin, Ding Hui, Li Lei, Chao Hongtu

机构信息

Department of Gynaecology, Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, China.

出版信息

Ann Transl Med. 2021 Sep;9(18):1463. doi: 10.21037/atm-21-4321.

DOI:10.21037/atm-21-4321
PMID:34734015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8506775/
Abstract

BACKGROUND

Caseinolytic protease P (CLPP) is a mitochondrial specific protein which has been reported to be related to tumor cell apoptosis. This study aims to explore the roles of CLPP in human epithelial ovarian cancer (EOC).

METHODS

We determined CLPP expression in paracancerous tissues and cancer tissues obtained from 20 EOC patients, and also in 4 EOC cell lines, and one normal ovarian cell line (IOSE-80). We knocked CLPP expression down in SK-OV-3 and A2780 cells and overexpressed it in SW626 and OVcar3 cells. The effect of CLPP expression on cell proliferation, mitochondrial membrane potential, and apoptosis was then assessed by flow cytometry assay. Furthermore, the effect of ONC201 (agonist of CLPP) on the EOC cell lines was also investigated.

RESULTS

The CLPP expression was markedly down-regulated in EOC cancer tissues, and the Kaplan-Meier Plotter database revealed its low expression was linked to poor prognosis in EOC patients. Low expression of CLPP up-regulated the expression of NADH: ubiquinone oxidoreductase subunit A12 (NDUFA12), succinate dehydrogenase complex flavoprotein subunit A (SDHA), and succinate dehydrogenase complex iron sulfur subunit B (SDHB), which are key members of the mitochondrial respiratory chain, and these up-regulated proteins further led to the increase of mitochondrial membrane potential, cell proliferation promotion and neoplasm metastasis. Conversely, while overexpression of CLPP led to the opposite results, including inducing the decrease of mitochondrial membrane potential and apoptosis. In addition, stimulation with ONC201 enhanced the function of CLPP in SW626 and OVcar3 cells, and silencing of CLPP could neutralize the effect of ONC201.

CONCLUSIONS

Our findings suggest that CLPP mediated mitochondrial dysfunction inhibits the proliferation and migration of EOC cells.

摘要

背景

酪蛋白溶解蛋白酶P(CLPP)是一种线粒体特异性蛋白,据报道与肿瘤细胞凋亡有关。本研究旨在探讨CLPP在人上皮性卵巢癌(EOC)中的作用。

方法

我们检测了20例EOC患者的癌旁组织和癌组织中CLPP的表达,以及4种EOC细胞系和1种正常卵巢细胞系(IOSE-80)中CLPP的表达。我们在SK-OV-3和A2780细胞中敲低CLPP表达,并在SW626和OVcar3细胞中过表达CLPP。然后通过流式细胞术检测CLPP表达对细胞增殖、线粒体膜电位和凋亡的影响。此外,还研究了ONC201(CLPP激动剂)对EOC细胞系的作用。

结果

EOC癌组织中CLPP表达明显下调,Kaplan-Meier Plotter数据库显示其低表达与EOC患者预后不良有关。CLPP低表达上调了线粒体呼吸链关键成员烟酰胺腺嘌呤二核苷酸:泛醌氧化还原酶亚基A12(NDUFA12)、琥珀酸脱氢酶复合物黄素蛋白亚基A(SDHA)和琥珀酸脱氢酶复合物铁硫亚基B(SDHB)的表达,这些上调的蛋白进一步导致线粒体膜电位升高、细胞增殖促进和肿瘤转移。相反,CLPP过表达则导致相反的结果,包括诱导线粒体膜电位降低和凋亡。此外,用ONC201刺激可增强CLPP在SW626和OVcar3细胞中的功能,而CLPP沉默可抵消ONC201的作用。

结论

我们的研究结果表明,CLPP介导的线粒体功能障碍抑制了EOC细胞的增殖和迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/93a301a8298e/atm-09-18-1463-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/ac5b4f04ec64/atm-09-18-1463-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/421a7dc21659/atm-09-18-1463-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/93a301a8298e/atm-09-18-1463-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/ac5b4f04ec64/atm-09-18-1463-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/421a7dc21659/atm-09-18-1463-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b557/8506775/93a301a8298e/atm-09-18-1463-f4.jpg

相似文献

1
Caseinolytic protease P (CLPP) activated by ONC201 inhibits proliferation and promotes apoptosis in human epithelial ovarian cancer cells by inducing mitochondrial dysfunction.ONC201激活的酪蛋白水解蛋白酶P(CLPP)通过诱导线粒体功能障碍抑制人上皮性卵巢癌细胞的增殖并促进其凋亡。
Ann Transl Med. 2021 Sep;9(18):1463. doi: 10.21037/atm-21-4321.
2
HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells.HSPA8 介导的 CLPP 蛋白稳定性调控顺铂耐药卵巢癌细胞中的线粒体自噬。
Acta Biochim Biophys Sin (Shanghai). 2024 Mar 25;56(3):356-365. doi: 10.3724/abbs.2023246.
3
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.ONC201对卵巢癌细胞及浆液性卵巢癌转基因小鼠模型的抗肿瘤和抗侵袭作用
Front Oncol. 2022 Mar 17;12:789450. doi: 10.3389/fonc.2022.789450. eCollection 2022.
4
ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.ClpP通过调节Src/PI3K/Akt信号通路来调控乳腺癌细胞的增殖、侵袭和凋亡。
PeerJ. 2020 Mar 10;8:e8754. doi: 10.7717/peerj.8754. eCollection 2020.
5
Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.异常纺锤样小头畸形相关蛋白通过调控上皮性卵巢癌细胞周期促进其增殖。
Gland Surg. 2022 Apr;11(4):687-701. doi: 10.21037/gs-22-29.
6
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.线粒体蛋白酶 ClpP 是抗癌化合物 ONC201 及其相关类似物的作用靶点。
ACS Chem Biol. 2019 May 17;14(5):1020-1029. doi: 10.1021/acschembio.9b00222. Epub 2019 May 1.
7
IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.IMP075靶向ClpP用于体内外结肠癌治疗
Biochem Pharmacol. 2022 Oct;204:115232. doi: 10.1016/j.bcp.2022.115232. Epub 2022 Aug 27.
8
Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.琥珀酸脱氢酶亚基B在体外抑制人卵巢癌中的AMPK-HIF-1α通路。
J Ovarian Res. 2014 Dec 10;7:115. doi: 10.1186/s13048-014-0115-1.
9
Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.线粒体基质蛋白酶 ClpP 激动剂通过破坏线粒体稳态抑制乳腺癌细胞中的癌症干细胞功能。
Cancer Res Commun. 2022 Oct 10;2(10):1144-1161. doi: 10.1158/2767-9764.CRC-22-0142.
10
Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.长链非编码RNA生长停滞特异性转录本5通过线粒体介导的凋亡途径参与卵巢癌细胞凋亡。
Oncol Rep. 2015 Dec;34(6):3212-21. doi: 10.3892/or.2015.4318.

引用本文的文献

1
A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications.鸟瞰肿瘤中线粒体未折叠蛋白反应:机制、进展与进一步应用。
Cell Death Dis. 2024 Sep 11;15(9):667. doi: 10.1038/s41419-024-07049-y.
2
ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells.ONC206 靶向 ClpP 诱导肝癌细胞线粒体功能障碍和保护性自噬。
Neoplasia. 2024 Sep;55:101015. doi: 10.1016/j.neo.2024.101015. Epub 2024 Jun 29.
3
The mitochondrial protease ClpP is a druggable target that controls VSMC phenotype by a SIRT1-dependent mechanism.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗。
BMJ. 2020 Nov 9;371:m3773. doi: 10.1136/bmj.m3773.
3
ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.ONC201 和伊马替尼:具有临床疗效的抗癌化合物。
线粒体蛋白酶 ClpP 是一个可药物治疗的靶点,它通过 SIRT1 依赖的机制控制 VSMC 表型。
Redox Biol. 2024 Jul;73:103203. doi: 10.1016/j.redox.2024.103203. Epub 2024 May 21.
4
A novel mitochondria-related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single-cell validation.一个新的与线粒体相关的核心基因特征,用于预测 CESC 单细胞验证中的预后和评估肿瘤微环境。
J Cell Mol Med. 2024 Apr;28(8):e18265. doi: 10.1111/jcmm.18265.
5
HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells.HSPA8 介导的 CLPP 蛋白稳定性调控顺铂耐药卵巢癌细胞中的线粒体自噬。
Acta Biochim Biophys Sin (Shanghai). 2024 Mar 25;56(3):356-365. doi: 10.3724/abbs.2023246.
Neoplasia. 2020 Dec;22(12):725-744. doi: 10.1016/j.neo.2020.09.005. Epub 2020 Oct 23.
4
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles.上皮性卵巢癌转移的当前见解——希望与障碍
Cell Oncol (Dordr). 2020 Aug;43(4):515-538. doi: 10.1007/s13402-020-00513-9. Epub 2020 May 16.
5
ClpP regulates breast cancer cell proliferation, invasion and apoptosis by modulating the Src/PI3K/Akt signaling pathway.ClpP通过调节Src/PI3K/Akt信号通路来调控乳腺癌细胞的增殖、侵袭和凋亡。
PeerJ. 2020 Mar 10;8:e8754. doi: 10.7717/peerj.8754. eCollection 2020.
6
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.环状 RNA(circRNA)-PGAM1 通过调控 miR-542-3p/CDC5L/PEAK1 通路促进上皮性卵巢癌的恶性进展。
Cancer Med. 2020 May;9(10):3500-3521. doi: 10.1002/cam4.2929. Epub 2020 Mar 13.
7
Organoid of ovarian cancer: genomic analysis and drug screening.卵巢癌类器官:基因组分析与药物筛选。
Clin Transl Oncol. 2020 Aug;22(8):1240-1251. doi: 10.1007/s12094-019-02276-8. Epub 2020 Jan 14.
8
Chemical Modulation of Human Mitochondrial ClpP: Potential Application in Cancer Therapeutics.化学调节人线粒体 ClpP:在癌症治疗中的潜在应用。
ACS Chem Biol. 2019 Nov 15;14(11):2349-2360. doi: 10.1021/acschembio.9b00347. Epub 2019 Jul 10.
9
Epithelial ovarian cancer: Evolution of management in the era of precision medicine.上皮性卵巢癌:精准医学时代的治疗进展。
CA Cancer J Clin. 2019 Jul;69(4):280-304. doi: 10.3322/caac.21559. Epub 2019 May 17.
10
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.线粒体 ClpP 介导线粒体蛋白酶体诱导选择性癌细胞死亡。
Cancer Cell. 2019 May 13;35(5):721-737.e9. doi: 10.1016/j.ccell.2019.03.014. Epub 2019 May 2.